CompaniesEnzymatics

Enzymatics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

5

As Collaborator

1

Total Enrollment

1,480

By Phase

NA: 6

By Status

COMPLETED: 5NOT_YET_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
NCT07041671
Hover over trial bars to see details

Recent Trials

NCT07041671Collaborator
Evaluation Viral RNA and Virus Infectivity in Exhaled Air Before and After Use of One Dose With ColdZyme Mouth Spray
NANot yet recruiting
200 participants
Started: Sep 30, 2025 · Completed: Dec 31, 2028
NCT03901846Lead Sponsor
Duration of ColdZyme® II
NACompleted
45 participants
Started: May 7, 2019 · Completed: Jul 25, 2019
NCT03794804Lead Sponsor
Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Common Cold
NACompleted
701 participants
Started: Jan 28, 2019 · Completed: Jun 26, 2019
NCT03831763Lead Sponsor
Evaluation of the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of ColdZyme Mouth Spray
NACompleted
400 participants
Started: Jan 25, 2018 · Completed: Jun 5, 2018
NCT02479750Lead Sponsor
Evaluation of ColdZyme® on Experimentally Induced Common Cold.
NACompleted
88 participants
Started: Mar 23, 2016 · Completed: Jul 25, 2016
View all 6 trials →
Funding History (1)
D
Aug 15, 2013
Filing
Enzymatics | Biotech Hunter | Biotech Hunter